Trial Details
TERMINATEDBasic Information
| Clinical ID | c1949 |
|---|---|
| Identifier | NCT04200547 |
| Trial Title | Interest of the Dosage of Adalimumab Serum Levels in Crohn's Disease Patients for Prevention of Postoperative Recurrence |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn Disease |
| Interventions | OTHER: Immunomonitoring-based follow-up|OTHER: Standard follow-up |
Participant Information
| Sponsor | University Hospital, Montpellier |
|---|---|
| City | Montpellier |
| Country/Region | France |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | NA |
Time Information
| Start Date | 2020-01-29 |
|---|---|
| Primary Completion Date | 2024-06-29 |
| Completion Date | 2024-06-29 |